Google Translate Limitations Disclaimer

The electronic translation service on the brainXchange website is hosted by Google Translate, an external translation service. The brainXchange does not guarantee or warrant the reliability, accuracy or completeness of any translated information. The basic translation goal is to capture the general information of the original English website content. If any questions arise related to the accuracy of the information contained in the translated website, please refer to the English version of the website.

Home > Events > Upcoming Events > Type 2 Diabetes and Cognitive Impairment: Assessing the Association Between the Use of Sodium Glucos

Type 2 Diabetes and Cognitive Impairment: Assessing the Association Between the Use of Sodium Glucos

Event Date: Jan 29, 2025

This webinar will give the opportunity to:

Review type 2 diabetes and cognitive impairment
Present findings from a population-based cohort study assessing the association between sodium glucose co-transporter-2 inhibitor use and the risk of incident dementia among people with type 2 diabetes

Presenter(s):

Dr. Oriana Yu completed her medical school at the University of Calgary and her residency and fellowship training at McGill University. She subsequently completed a Masters’ of Science in Epidemiology at McGill University. Dr. Yu is an Associate Professor at McGill University and staff endocrinologist at the Jewish General Hospital. She has successfully conducted clinical and pharmacoepidemiologic research. Her work has focused on addressing drug efficacy and safety in diabetes management and metabolic disorders.